Acrolein is a highly reactive unsaturated aldehyde best known pharmaceutically as a urotoxic metabolite of cyclophosphamide and ifosfamide chemotherapy, making it an important genotoxic-impurity reference compound rather than a therapeutic agent in its own right. Simson Pharma supplies an Acrolein reference standard for genotoxic impurity testing in oxazaphosphorine-class anticancer drug manufacturing.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Acrolein Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.